H.R. 7537: Corporate Crimes Against Health Care Act
The "Corporate Crimes Against Health Care Act" introduces measures to address and penalize misconduct within healthcare organizations that result in patient harm or fatalities. The key elements of the bill include:
Establishment of Penalties
The bill aims to impose criminal and civil penalties on individuals associated with healthcare organizations who have engaged in unjust enrichment following patient injuries or deaths. This means that if a healthcare provider benefits financially inappropriately after a serious event involving a patient, they could face legal repercussions.
Clawback Provisions
It allows for the recovery of compensation that was awarded to these individuals if the award is found to be tied to the circumstances surrounding incidents of harm. This provision is aimed at discouraging fraudulent or negligent practices by holding individuals accountable for their financial gains linked to patient outcomes.
Focus on Health Plans
The bill includes specific measures pertaining to health plans, requiring evaluations according to designated codes. This may involve assessing the financial relationships and returns derived from healthcare practices to ensure fairness and accountability within the system.
Assessment of Federal Policies
Additionally, the legislation mandates an evaluation of current federal policies designed to combat healthcare fraud. This assessment will aim to enhance transparency and strengthen penalties related to fraudulent activities, especially amidst increasing consolidation trends in the healthcare sector, which can lead to reduced competition and heightened risk of misconduct.
Impact on Transparency
Overall, the provisions of the bill are geared toward increasing the scrutiny of healthcare practices, deterring fraudulent activities, and reinforcing ethical standards across the healthcare system.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 12, 2026 | Introduced in House |
| Feb. 12, 2026 | Referred to the Committee on Ways and Means, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.